|
Index of reports
> Hospitalization (89)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Epirubicin hospitalization. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 89 Next >>
Possible Epirubicin side effects in
Reported by a health professional (non-physician/pharmacist) from Italy on 2012-08-20
Patient:
Reactions: Abdominal Pain, Vomiting, Hypersensitivity, Nausea, Skin Toxicity, Mucosal Inflammation, Fatigue, Diarrhoea, Hepatotoxicity, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lapatinib
Dosage: arm b
Administration route: Oral
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Lapatinib
Dosage: arm c
Administration route: Oral
Herceptin
Dosage: loading dose
Indication: Breast Cancer
Herceptin
Dosage: maintenance dose
Fluorouracil
Indication: Breast Cancer
Paclitaxel
Indication: Breast Cancer
Epirubicin
Indication: Breast Cancer
Possible Epirubicin side effects in female
Reported by a physician from Netherlands on 2012-07-30
Patient: female, weighing 61.5 kg (135.3 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
NO Treatment Received
Dosage: no treatment received
Indication: Breast Cancer
Epirubicin
Dosage: 177 mg, unk
Indication: Breast Cancer
Start date: 2011-03-22
Fluorouracil
Dosage: 885 mg, unk
Indication: Breast Cancer
Start date: 2011-03-22
Cyclophosphamide
Dosage: 885 mg, unk
Indication: Breast Cancer
Start date: 2011-03-22
Other drugs received by patient: Granisetron
Possible Epirubicin side effects in 57 year old female
Reported by a consumer/non-health professional from Spain on 2012-07-27
Patient: 57 year old female
Reactions: Pyrexia, Neutropenia, Hidradenitis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2006-08-23
End date: 2006-11-02
Docetaxel
Indication: Breast Cancer
Start date: 2006-08-23
End date: 2006-11-02
Other drugs received by patient: Hipoartel; Simvastatin; Ceftazidime; Pantoprazole
Possible Epirubicin side effects in 58 year old female
Reported by a physician from Taiwan, Province of China on 2012-07-24
Patient: 58 year old female, weighing 57.3 kg (126.1 pounds)
Reactions: Multi-Organ Failure, Pneumonia, Coagulopathy, Central Nervous System Lesion, Acute Respiratory Distress Syndrome, Neutropenia, Acute Respiratory Failure, Renal Failure Acute
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Start date: 2010-12-28
End date: 2010-12-28
Taxotere
Indication: Breast Cancer
Start date: 2010-09-30
End date: 2010-09-30
Taxotere
Start date: 2010-12-28
End date: 2010-12-28
Epirubicin
Indication: Breast Cancer
Start date: 2010-09-30
End date: 2010-09-30
Other drugs received by patient: Granocyte
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23
Patient: female, weighing 61.2 kg (134.6 pounds)
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-30
Epirubicin
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-02
End date: 2009-12-02
Fluorouracil
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-02
End date: 2009-12-02
Fluorouracil
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-30
Cyclophosphamide
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-02
End date: 2009-12-02
Cyclophosphamide
Dosage: see image
Indication: Breast Cancer
Start date: 2009-12-30
Possible Epirubicin side effects in 65 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-07-23
Patient: 65 year old female, weighing 51.8 kg (114.0 pounds)
Reactions: Acinetobacter Infection, Postoperative Wound Infection, Postoperative Wound Complication, Wound Infection Staphylococcal
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: df, every three weeks intravenous, df, every three weeks intravenous
Indication: Breast Cancer
Start date: 2010-08-07
End date: 2010-08-07
Fluorouracil
Dosage: df, every three weeks intravenous, df, every three weeks intravenous
Indication: Breast Cancer
Start date: 2010-09-09
Cyclophosphamide
Dosage: df, every three weeks intravenous, df, every three weeks intravenous
Start date: 2010-08-07
Cyclophosphamide
Dosage: df, every three weeks intravenous, df, every three weeks intravenous
Start date: 2010-09-09
Epirubicin
Dosage: df, every three weeks intravenous, df, every three weeks intravenous
Indication: Breast Cancer
Start date: 2010-09-09
Epirubicin
Dosage: df, every three weeks intravenous, df, every three weeks intravenous
Indication: Breast Cancer
Start date: 2010-08-07
End date: 2010-08-07
Other drugs received by patient: Granisetron; Dexamethasone; Lamivudine; Metoclopramide Hydrochloride
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-01-05
End date: 2011-01-05
Cyclophosphamide
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-02-16
End date: 2011-02-16
Cyclophosphamide
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2010-12-08
Fluorouracil
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-01-05
End date: 2011-01-05
Fluorouracil
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-02-16
End date: 2011-02-16
Fluorouracil
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2010-12-08
Epirubicin
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-02-16
End date: 2011-02-16
Epirubicin
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2010-12-08
Epirubicin
Dosage: every cycle intravenous, every cycle intravenous, every cycle intravenous
Indication: Breast Cancer
Start date: 2011-01-05
End date: 2011-01-05
Other drugs received by patient: Dexamethasone; Ondansetron
Possible Epirubicin side effects in 48 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-23
Patient: 48 year old female
Reactions: Vomiting, Nausea, Febrile Neutropenia, Oropharyngeal Pain
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Epirubicin
Dosage: 166mg every cycle; 140mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-06
Fluorouracil
Dosage: 830 mg every cycle; 700 mg, every cycle
Indication: Breast Cancer
Start date: 2010-10-27
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-27
Cyclophosphamide
Dosage: 830mg, every cycle; 800mg, every cycle
Indication: non-Small Cell Lung Cancer
Start date: 2010-10-06
End date: 2010-10-06
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-23
Patient: female
Reactions: Diarrhoea, Chills, Febrile Neutropenia, Headache
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: every cycle
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2011-01-05
Cyclophosphamide
Dosage: every cycle
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2011-01-05
Fluorouracil
Dosage: every cycle
Indication: Breast Cancer
Start date: 2010-12-08
End date: 2011-01-05
Other drugs received by patient: Dexamethasone; Onsia
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from Thailand on 2012-07-20
Patient: female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2009-10-29
End date: 2009-10-29
Cyclophosphamide
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2010-01-04
End date: 2010-01-04
Fluorouracil
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2010-01-04
End date: 2010-01-04
Fluorouracil
Dosage: (800 mg; every cycle), (800 mg; every cycle)
Indication: Breast Cancer
Start date: 2009-10-29
End date: 2009-10-29
Epirubicin
Dosage: (150 mg; every cycle), (150 mg; every cycle)
Indication: Breast Cancer
Start date: 2010-01-04
End date: 2010-01-04
Epirubicin
Dosage: (150 mg; every cycle), (150 mg; every cycle)
Indication: Breast Cancer
Start date: 2009-10-29
End date: 2009-10-29
Other drugs received by patient: Ondansetron; Lenograstim; Dexamethasone
Possible Epirubicin side effects in 63 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20
Patient: 63 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Cyclophosphamide
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Fluorouracil
Dosage: (df; every cycle), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-06-30
End date: 2010-06-30
Possible Epirubicin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 44 year old female, weighing 55.5 kg (122.1 pounds)
Reactions: Abdominal Pain, Intestinal Ischaemia, Colitis Ischaemic, White Blood Cell Count Decreased, Vomiting, Blood Creatine Phosphokinase Increased, Gastrointestinal Necrosis, Pyrexia, Multi-Organ Failure, Diarrhoea, GAS Gangrene, Heart Rate Increased, Bone Marrow Failure, Neutropenia, Clostridial Infection
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Epirubicin
Dosage: 7 cycles, total 4 courses
Indication: Breast Cancer
Start date: 2011-07-22
End date: 2011-09-22
Taxotere
Dosage: 4 cycles, total 3 courses, dose taken once daily
Indication: Breast Cancer
Start date: 2011-10-14
End date: 2011-11-25
Other drugs received by patient: Leucon; Lorazepam; Decadron Phosphate; Lorazepam; Kytril; Prochlorperazine; Kytril; Cepharanthin; Decadron Phosphate; Marzulene S
Possible Epirubicin side effects in 58 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20
Patient: 58 year old female
Reactions: Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: (df; every three weeks intravenous drip), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-08-04
End date: 2010-08-04
Fluorouracil
Dosage: (df; every three weeks intravenous drip), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-08-04
End date: 2010-08-04
Cyclophosphamide
Dosage: (df; every three weeks intravenous drip), (df; dose reduced intravenous drip)
Indication: Breast Cancer
Start date: 2010-08-04
End date: 2010-08-04
Possible Epirubicin side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from Hong Kong on 2012-07-20
Patient: 62 year old female
Reactions: Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: (df), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-07-23
End date: 2010-07-23
Fluorouracil
Dosage: (df), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-07-23
End date: 2010-07-23
Cyclophosphamide
Dosage: (df), (df; dose reduced)
Indication: Breast Cancer
Start date: 2010-07-23
End date: 2010-07-23
Possible Epirubicin side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-09
Patient: female
Reactions: Drug Intolerance, Tongue Neoplasm Malignant Stage Unspecified
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Neoplasm
Start date: 2011-08-01
Cyclophosphamide
Dosage: 14 days on 21 days
Start date: 2011-02-01
End date: 2011-07-01
Doxorubicin HCL
Dosage: 9 courses
Indication: Product Used FOR Unknown Indication
Start date: 2009-02-19
End date: 2009-11-05
Taxotere
Indication: Product Used FOR Unknown Indication
Start date: 2005-03-08
End date: 2005-04-19
Doxorubicin HCL
Dosage: 8 courses
Start date: 2007-11-27
End date: 2008-06-24
Cyclophosphamide
Start date: 2004-12-03
End date: 2005-02-02
Fluorouracil
Indication: Product Used FOR Unknown Indication
Start date: 2004-12-03
End date: 2005-02-02
Epirubicin
Indication: Product Used FOR Unknown Indication
Start date: 2004-12-03
End date: 2005-02-02
Other drugs received by patient: Aromasin; Navoban; Xeloda; Faslodex; Estracyt; Femara; Arimidex; Navelbine
Possible Epirubicin side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-06-15
Patient: male
Reactions: Metastases To Adrenals, Neuroblastoma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Start date: 2007-01-01
End date: 2007-01-01
Cyclophosphamide
Start date: 2007-01-01
End date: 2007-01-01
Fluorouracil
Start date: 2007-01-01
End date: 2007-01-01
Possible Epirubicin side effects in female
Reported by a individual with unspecified qualification from Germany on 2012-06-07
Patient: female
Reactions: Vomiting, Nausea, Inappropriate Antidiuretic Hormone Secretion, Coma
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer
Start date: 2012-04-16
End date: 2012-04-16
Cyclophosphamide
Indication: Breast Cancer
Start date: 2012-04-16
End date: 2012-04-16
Other drugs received by patient: Prednisone TAB; Dexamethasone; Sodium Chloride; Aprepitant; Mesna; Granisetron; Hydroxychloroquine Sulfate
Possible Epirubicin side effects in 69 year old female
Reported by a consumer/non-health professional from France on 2012-05-31
Patient: 69 year old female, weighing 62.0 kg (136.4 pounds)
Reactions: Malaise, Hyperthermia, Febrile Bone Marrow Aplasia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 100 mg/m2, unk
Indication: Breast Cancer
Start date: 2012-03-29
Fluorouracil
Dosage: 500 mg/m2, unk
Indication: Breast Cancer
Start date: 2012-03-29
Cyclophosphamide
Dosage: 100 mg/m2, unk
Indication: Breast Cancer
Start date: 2012-03-29
Neulasta
Dosage: 6 mg, one time dose
Indication: Chemotherapy
Start date: 2012-03-30
End date: 2012-03-30
Other drugs received by patient: Motilium / 00498201 /
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-30
Patient: 49 year old female
Reactions: Multi-Organ Failure, Lymphocytosis, Acute Lymphocytic Leukaemia, Refractory Anaemia, Pneumonia, Septic Shock
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Methotrexate
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Vincristine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Doxorubicin HCL
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cytarabine
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cyclophosphamide
Dosage: 100 mg
Administration route: Oral
Indication: Anaemia
Prednisolone
Indication: Leukocytosis
Fluorouracil
Indication: Breast Cancer
Dexamethasone
Indication: Acute Lymphocytic Leukaemia
Start date: 2009-07-01
Cyclophosphamide
Indication: Breast Cancer
Cyclophosphamide
Indication: Leukocytosis
Start date: 2009-07-01
Epirubicin
Indication: Breast Cancer
Prednisolone
Dosage: 15 mg
Indication: Anaemia
Cyclophosphamide
Indication: Acute Lymphocytic Leukaemia
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-25
Patient: 49 year old female
Reactions: Acute Lymphocytic Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer Stage II
Fluorouracil
Indication: Breast Cancer Stage II
Epirubicin
Indication: Breast Cancer Stage II
Possible Epirubicin side effects in male
Reported by a consumer/non-health professional from China on 2012-05-24
Patient: male, weighing 60.0 kg (132.0 pounds)
Reactions: Off Label Use, Rash Erythematous, Gastric Cancer
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Indication: Gastric Cancer Stage III
Doxorubicin HCL
Indication: Gastric Cancer Stage III
Doxorubicin HCL
Start date: 2011-10-30
End date: 2011-11-02
Doxorubicin HCL
Epirubicin
Indication: Gastric Cancer Stage III
Cytoxan
Indication: Gastric Cancer Stage III
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-22
Patient: 49 year old female
Reactions: Acute Lymphocytic Leukaemia
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Epirubicin
Indication: Breast Cancer Stage II
Cytoxan
Indication: Breast Cancer Stage II
Fluorouracil
Indication: Breast Cancer Stage II
Possible Epirubicin side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-22
Patient: 44 year old female
Reactions: Atrial Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 3 cycles.
Indication: Breast Cancer
Epirubicin
Dosage: 3 cycles.
Indication: Breast Cancer
Cyclophosphamide
Dosage: 3 cycles.
Indication: Breast Cancer
Taxotere
Dosage: 3 cycles.
Indication: Breast Cancer
Trastuzumab
Dosage: 3 cycles.
Indication: Breast Cancer
Start date: 2009-01-01
End date: 2010-07-06
Other drugs received by patient: Amlodipine Besylate
Possible Epirubicin side effects in 70 year old female
Reported by a physician from Germany on 2012-05-21
Patient: 70 year old female, weighing 67.0 kg (147.4 pounds)
Reactions: Arrhythmia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Fluorouracil
Dosage: 868 mg, qd
Pegfilgrastim
Dosage: 6 mg, unk
Indication: Prophylaxis
Start date: 2012-01-25
Cytoxan
Dosage: 868 mg, qd
Epirubicin
Dosage: 174 mg, qd
Other drugs received by patient: Dexamethasone; Mesna; Docetaxel; ACE Inhibitors; Aloxi; Fosaprepitant Dimeglumine; Insulin
Possible Epirubicin side effects in 67 year old male
Reported by a consumer/non-health professional from United Kingdom on 2012-05-18
Patient: 67 year old male, weighing 85.0 kg (187.0 pounds)
Reactions: Gastrointestinal Anastomotic Leak, Post Procedural Haemorrhage
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Capecitabine
Dosage: 5250 mg, unk
Administration route: Oral
Start date: 2011-12-08
Cisplatin
Dosage: unk
Indication: Gastric Cancer
Start date: 2011-09-22
Bevacizumab
Dosage: 655 mg, unk
Start date: 2011-11-17
Capecitabine
Dosage: unk
Administration route: Oral
Indication: Gastric Cancer
Start date: 2011-09-22
Cisplatin
Dosage: 120 mg, unk
Start date: 2011-11-17
Epirubicin
Dosage: unk
Indication: Gastric Cancer
Start date: 2011-09-22
Bevacizumab
Dosage: unk
Indication: Gastric Cancer
Start date: 2011-09-22
Epirubicin
Dosage: 50 mg, unk
Start date: 2011-11-17
Possible Epirubicin side effects in female
Reported by a physician from Germany on 2012-05-18
Patient: female, weighing 110.0 kg (242.0 pounds)
Reactions: Vomiting, Nasopharyngitis, Nausea, Diarrhoea, Pyrexia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Epirubicin
Dosage: 200 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
NO Treatment Received
Dosage: no treatment
Indication: Breast Cancer
Fluorouracil
Dosage: 100 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
Cyclophosphamide
Dosage: 1000 mg, unk
Start date: 2010-11-05
End date: 2011-01-07
Other drugs received by patient: Paracodin Bitartrate TAB; Cefuroxime; Acetylcysteine; Allopurinol
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-18
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Multi-Organ Failure, Death, Lymphocytosis, Dizziness, Asthenia, Septic Shock, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cytoxan
Dosage: 100 mg, unk
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in 44 year old female
Reported by a physician from France on 2012-05-17
Patient: 44 year old female
Reactions: Atrial Thrombosis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Herceptin
Indication: Breast Cancer
End date: 2010-07-06
Epirubicin
Indication: Breast Cancer
Fluorouracil
Indication: Breast Cancer
Cyclophosphamide
Indication: Breast Cancer
Taxotere
Indication: Breast Cancer
Other drugs received by patient: Amlodipine Besylate
Possible Epirubicin side effects in 49 year old female
Reported by a health professional (non-physician/pharmacist) from Taiwan, Province of China on 2012-05-15
Patient: 49 year old female
Reactions: Pneumonia, Anaemia, Pancytopenia, Pyrexia, B Precursor Type Acute Leukaemia, Lymphocytosis, Multi-Organ Failure, Death, Dizziness, Septic Shock, Asthenia, Leukocytosis, Decreased Appetite
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Fluorouracil
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Epirubicin
Indication: Breast Cancer Stage II
Start date: 2008-03-01
Possible Epirubicin side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-05-09
Patient: 67 year old male
Reactions: Liver Abscess
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
TSU-68
Administration route: Oral
Indication: Hepatic Neoplasm Malignant
Start date: 2012-03-16
End date: 2012-03-19
Epirubicin
Indication: Hepatic Neoplasm Malignant
Start date: 2012-03-06
Other drugs received by patient: Metilon; Glycyron / 00466401 /; Zolpidem; Rabeprazole Sodium; Ursodiol
Page 1 Next >>
|
